FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib

被引：0

作者：

Lixia Gao

Xuli Wang

Yaoliang Tang

Shuang Huang

Chien-An Andy Hu

Yong Teng

机构：

[1] Augusta University,Department of Oral Biology, Dental College of Georgia

[2] University of Utah,Department of Radiology and Imaging Sciences, School of Medicine

[3] University of Utah,Experimental Therapeutics Program, Huntsman Cancer Institute

[4] Augusta University,Vascular Biology Center, Department of Medicine, Medical College of Georgia

[5] University of Florida College of Medicine,Department of Anatomy and Cell Biology

[6] University of New Mexico School of Medicine,Department of Biochemistry and Molecular Biology

[7] Augusta University,Department of Biochemistry and Molecular Biology, Medical College of Georgia

来源：

Journal of Experimental & Clinical Cancer Research | / 36卷

关键词：

FGF19; FGFR4; Hepatocellular carcinoma; Drug resistance; Sorafenib; Synergistic effect;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
Gao, Lixia
Wang, Xuli
Tang, Yaoliang
Huang, Shuang
Hu, Chien-An Andy
Teng, Yong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
[2] The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
Kanzaki, Hiroaki
Chiba, Tetsuhiro
Ao, Junjie
Koroki, Keisuke
Kanayama, Kengo
Maruta, Susumu
Maeda, Takahiro
Kusakabe, Yuko
Kobayashi, Kazufumi
Kanogawa, Naoya
Kiyono, Soichiro
Nakamura, Masato
Kondo, Takayuki
Saito, Tomoko
Nakagawa, Ryo
Ogasawara, Sadahisa
Suzuki, Eiichiro
Ooka, Yoshihiko
Muroyama, Ryosuke
Nakamoto, Shingo
Yasui, Shin
Tawada, Akinobu
Arai, Makoto
Kanda, Tatsuo
Maruyama, Hitoshi
Mimura, Naoya
Kato, Jun
Zen, Yoh
Ohtsuka, Masayuki
Iwama, Atsushi
Kato, Naoya
SCIENTIFIC REPORTS, 2021, 11 (01)
[3] FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
Gao, Lixia
Lang, Liwei
Zhao, Xiangdong
Shay, Chloe
Shull, Austin Y.
Teng, Yong
ONCOGENE, 2019, 38 (13) : 2394 - 2404
[4] FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression
Zhao, Xiangdong
Xu, Faliang
Dominguez, Nestor P.
Xiong, Yuanping
Xiong, Zhongxun
Peng, Hong
Shay, Chloe
Teng, Yong
MOLECULAR CARCINOGENESIS, 2018, 57 (11) : 1616 - 1625
[5] FGF19-FGFR4 Signaling in Hepatocellular Carcinoma
Raja, Aroosha
Park, Inkeun
Haq, Farhan
Ahn, Sung-Min
CELLS, 2019, 8 (06)
[6] Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer
Motylewska, Ewelina
Stepien, Tomasz
Borkowska, Magdalena
Kuzdak, Krzysztof
Siejka, Agnieszka
Komorowski, Jan
Stepien, Henryk
Lawnick, Hanna
CYTOKINE, 2018, 105 : 32 - 36
[7] Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment
Kaibori, Masaki
Sakai, Kazuko
Ishizaki, Morihiko
Matsushima, Hideyuki
De Velasco, Marco A.
Matsui, Kosuke
Iida, Hiroya
Kitade, Hiroaki
Kwon, A-Hon
Nagano, Hiroaki
Wada, Hiroshi
Haji, Seiji
Tsukamoto, Tadashi
Kanazawa, Akishige
Takeda, Yutaka
Takemura, Shigekazu
Kubo, Shoji
Nishio, Kazuto
ONCOTARGET, 2016, 7 (31) : 49091 - 49098
[8] Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report
Lixia Gao
Chloe Shay
Fenglin Lv
Xuli Wang
Yong Teng
Cellular Oncology, 2018, 41 : 85 - 91
[9] Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL
Zhu, Z.
Hu, B.
Zhu, D.
Li, X.
Chen, D.
Wu, N.
Rao, Q.
Zhang, Z.
Wang, H.
Zhu, Y.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2025, 48 (01) : 67 - 80
[10] Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report
Gao, Lixia
Shay, Chloe
Lv, Fenglin
Wang, Xuli
Teng, Yong
CELLULAR ONCOLOGY, 2018, 41 (01) : 85 - 91

← 1 2 3 4 5 →